Gilead Sciences, Inc.
Source: SEC Form 13F · as of Mar 2026Gilead Sciences, Inc. holds 5 biotech & pharma companies tracked by BioSniper, totaling $2.11B in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$2.11B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Arcellx, Inc. (ACLX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ACLXArcellx, Inc. | 6,720,803 | $771.7M |
| RCUSArcus Biosciences, Inc. | 31,424,760 | $678.8M |
| LKFTLakefront Biotherapeutics NV | 16,707,477 | $501.2M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 4,505,391 | $125.0M |
| KYTXKyverna Therapeutics, Inc. | 4,126,119 | $35.6M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.